Navigation Links
Array Announces Global Phase 3 Trial Evaluating MEK162 In Patients With Low-Grade Serous Ovarian Cancer
Date:5/6/2013

BOULDER, Colo., May 6, 2013 /PRNewswire/ -- Array BioPharma Inc. (NASDAQ: ARRY) today announced that it will initiate a global Phase 3 clinical trial in patients with recurrent low-grade serous ovarian cancer (LGSOC) during the summer of 2013.  The study, called MILO (MEK Inhibitor in Low Grade Serous Ovarian Cancer), will evaluate the efficacy and safety of MEK162 compared to standard chemotherapy treatments and is designed for worldwide regulatory submissions, including with the U.S. Food and Drug Administration and the European Medicines Agency.  Array invented MEK162 and licensed worldwide rights to develop and commercialize the drug to Novartis in April 2010.  The MILO study follows a recent announcement by Novartis detailing plans to initiate Phase 3 trials of MEK162 in both NRAS- and BRAF-mutant melanoma and will be covered as part of the Novartis/Array co-development agreement under which costs are capped annually and in total for Array.  

(Logo: http://photos.prnewswire.com/prnh/20121029/LA02195LOGO)

"We have seen encouraging early clinical results using a MEK inhibitor in patients with recurrent low-grade serous cancer when compared to the historic data of cytotoxic chemotherapy, the current standard of care," said Bradley J. Monk , MD, Director of the Division of Gynecologic Oncology at the University of Arizona Cancer Center at St. Joseph's Hospital in Phoenix and at the Creighton University School of Medicine. "There remains a significant unmet medical need for effective treatment in low-grade serous ovarian cancer and I look forward to investigating MEK162 in this Phase 3 study."

The multinational, ran
'/>"/>

SOURCE Array BioPharma
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Global Array Instrument Market is Expected to Reach USD 3.2 Billion Globally in 2017: Transparency Market Research
2. Array BioPharma Reports Financial Results For The First Quarter Of Fiscal 2013
3. Array BioPharma To Present Clinical Data On ARRY-797 At The 2012 American College Of Rheumatology Annual Meeting
4. Array BioPharma Announces Proposed Public Offering Of Common Stock
5. Array BioPharma Announces Pricing Of Public Offering Of Common Stock
6. Array BioPharma To Present At The Piper Jaffray Annual Healthcare Conference
7. InternetArray Collaborates with Health Sciences Group to Fund Medical Marijuana Social Media/Mobile Apps Development
8. Array BioPharma To Present At The Leerink Swann Global Healthcare Conference
9. Zacks Bull and Bear of the Day Highlights: Fortune Brands Home & Security, Wal-Mart Stores, Regeneron Pharmaceuticals, Bayer and Array Biopharma
10. Array BioPharma To Present At The Cowen Annual Health Care Conference
11. Array BioPharma Names Michael N. Needle, M.D. As Chief Medical Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... HOUSTON , Oct. 22, 2014  Charlene Vernak, RPh, ... York , recently was awarded the George Roentsch ... Vernak received the award in Houston ... The scholarship is awarded annually to an independent pharmacist ... nature of George Roentsch , a well-known pharmacist ...
(Date:10/22/2014)... Oregon , October 22, 2014 ... "Global Disposable Gloves Market (Product type, Form, End user, ... Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and ... global disposable gloves market. Based on key trends tracked, ... be valued at $7.9 billion by 2020, registering a ...
(Date:10/22/2014)... , Oct. 21, 2014  Early symptoms ... subtle or unnoticed, but new technology, coupled with ... and leading to earlier detection of eye diseases, ... 29 million Americans. If left untreated, these diseases ... blindness. Recently, optometric researchers have ...
Breaking Medicine Technology:PCCA Awards Charlene Vernak, RPh, the George Roentsch Scholarship 2Global Disposable Gloves Market Expected to Grow to $7.9 Billion by 2020 - Allied Market Research 2Global Disposable Gloves Market Expected to Grow to $7.9 Billion by 2020 - Allied Market Research 3Global Disposable Gloves Market Expected to Grow to $7.9 Billion by 2020 - Allied Market Research 4Technology Advancements Enhance Early Detection of Eye Diseases Associated with Diabetes 2Technology Advancements Enhance Early Detection of Eye Diseases Associated with Diabetes 3
... Delcath Systems, Inc. (Nasdaq: DCTH ), a developmental stage ... that it will open the NASDAQ stock market on Friday, ... Times Square in New York City will be broadcast ... NASDAQ webcam. The live ceremony, including President and Chief Executive Officer ...
... Inc. (Nasdaq: MYL ) today announced that it increased the ... pricing.  Mylan priced $550 million aggregate principal amount of ... and $700 million aggregate principal amount of 7.875% Senior ... to use approximately $1.0 billion of the net proceeds ...
Cached Medicine Technology:Delcath's Eamonn Hobbs to Ring NASDAQ Opening Bell 2Mylan Announces Upsizing and Pricing of Senior Notes 2Mylan Announces Upsizing and Pricing of Senior Notes 3
(Date:10/22/2014)... WALTHAM, MA (PRWEB) October 22, 2014 ... developing new solutions for the treatment of bacterial infections, ... J. Sinskey has joined its board of directors. ... Microbiology and Engineering Systems at The Massachusetts Institute of ... the MIT faculty since 1968. Dr. Sinskey also holds ...
(Date:10/22/2014)... HealthDay Reporter , TUESDAY, Oct. ... men may lead to increased blood pressure, according to a ... rise in blood pressure for young adult women or for ... women drank lightly or moderately, their risk of high blood ... finding parallels studies in older adult men and women," said ...
(Date:10/22/2014)... Dennis Thompson HealthDay Reporter TUESDAY, ... diagnosed with Ebola while working for NBC News in ... the special isolation unit at Nebraska Medical Center in Omaha, where ... said Tuesday. A blood test confirmed by the U.S. Centers ... head home to Providence, R.I., NBC News reported Tuesday ...
(Date:10/20/2014)... MA (PRWEB) October 20, 2014 ... sponsoring a booth at the American Foundation for Suicide ... 25th. The AFSP is a not-for-profit organization that hosts ... Net proceeds from these events are used to help ... but education and personal relationships as well. , ...
(Date:10/20/2014)... IN (PRWEB) October 20, 2014 ... Start, a secure cloud solution that enables healthcare ... of the ultimate healthcare-specific customer relationship management (“CRM”) ... meet the unique needs of the healthcare industry, ... experience for providers and patients by combining healthcare ...
Breaking Medicine News(10 mins):Health News:Akeso Biomedical Appoints Dr. Anthony J. Sinskey to Board of Directors 2Health News:Binge Drinking May Boost Blood Pressure in Young Men 2Health News:Binge Drinking May Boost Blood Pressure in Young Men 3Health News:Binge Drinking May Boost Blood Pressure in Young Men 4Health News:U.S. Cameraman Treated for Ebola 'Free' of the Virus 2Health News:U.S. Cameraman Treated for Ebola 'Free' of the Virus 3Health News:The Advocator Group, LLC is Proud to Participate in an Out of the Darkness Community Walk, October 25th, to Increase Suicide Awareness 2Health News:The Advocator Group, LLC is Proud to Participate in an Out of the Darkness Community Walk, October 25th, to Increase Suicide Awareness 3Health News:Healthcare Relationship Management (HRM) Leader hc1.com® Launches hc1® Quick Start™ 2
... posture support/brace, designed to combat rounded shoulders syndrome, which can cause ... working at a computer, more people are suffering the effects of ... can be worn everyday. , ... (PRWEB) August 1, ...
... ... ... ), a leading pharmaceutical, biotechnology and medical device research and,development ... has appointed Mr. Steven M. Hutchins as,Vice President of Business Development., (Logo: ...
... Bipartisan Leadership in,Helping to Avert $770 Million FY ... Seniors, WASHINGTON, July 31 The American ... Nursing Home Care applaud,today,s decision by the Bush ... of key Republican and Democratic congressional,leaders with spearheading ...
... Unit in Leeds receives Lilly,s 2008 Global ... ... Inc. (NYSE:,CVD), a leading provider of drug development services, today announced ... Lilly and Company., Covance,s clinical research unit based in Leeds, ...
... GXDX ), a specialized laboratory services provider, today reported,revenues ... and $50.1 million,for the first half of 2008, as ... the respective periods in 2007. Stated revenue for the,first ... changes in,accounting estimates relating to prior periods., "Our ...
... 31 Handa Pharmaceuticals, LLC,("Handa"), a specialty ... that its Abbreviated New Drug Application ("ANDA") ... of,AstraZeneca,s SEROQUEL(R) XR, has been accepted for ... ("FDA"). Based upon available information, Handa,believes that ...
Cached Medicine News:Health News:Bad Backs Essential Shoulder Brace - Now Available at badbackstore.com 2Health News:Bad Backs Essential Shoulder Brace - Now Available at badbackstore.com 3Health News:Bad Backs Essential Shoulder Brace - Now Available at badbackstore.com 4Health News:WuXi PharmaTech (NYSE: WX) Appoints Mr. Steven M. Hutchins as VP of Business Development 2Health News:AHCA-Alliance Praise Bush Administration for Reversing Planned Medicare Cuts, Protecting Seniors 2Health News:Covance Recognized for Outstanding Customer Service by Eli Lilly and Company 2Health News:Genoptix Reports Strong Financial Results for the Second Quarter and Raises Guidance for Full-Year 2008 2Health News:Genoptix Reports Strong Financial Results for the Second Quarter and Raises Guidance for Full-Year 2008 3Health News:Genoptix Reports Strong Financial Results for the Second Quarter and Raises Guidance for Full-Year 2008 4Health News:Genoptix Reports Strong Financial Results for the Second Quarter and Raises Guidance for Full-Year 2008 5Health News:Genoptix Reports Strong Financial Results for the Second Quarter and Raises Guidance for Full-Year 2008 6Health News:Genoptix Reports Strong Financial Results for the Second Quarter and Raises Guidance for Full-Year 2008 7Health News:Genoptix Reports Strong Financial Results for the Second Quarter and Raises Guidance for Full-Year 2008 8Health News:Genoptix Reports Strong Financial Results for the Second Quarter and Raises Guidance for Full-Year 2008 9Health News:Handa Pharmaceuticals Announces Submission of its First-to-File ANDA for AstraZeneca's SEROQUEL(R) XR 2
Anesthesia Associates Nerve Stimulator Model AA 1050...
... A range of easy to use instruments ... nerve locator, peripheral nerve stimulator, and muscle ... pole, plastic hub, and pencil point needles., ... inexpensive, practical and easy to use stimulator, ...
... nerve stimulator from B. Braun Medical. It ... stimulator functionality for over 10 years. , ... a unique, under-the-glove hand held remote current ... It allows the anesthesia provider operating solo ...
... the original MS-III design the ... enhanced keypad and ... MiniStim® MS-IV peripheral nerve stimulator ... monitoring in operating room, post ...
Medicine Products: